Two Sigma Advisers’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-99,141
| Closed | -$1.66M | – | 2621 |
|
|
2025
Q2 | $1.66M | Buy |
+99,141
| New | +$1.75M | ﹤0.01% | 1203 |
|
|
2023
Q4 | – | Sell |
-65,041
| Closed | -$2.61M | – | 2635 |
|
|
2023
Q3 | $2.61M | Sell |
65,041
-142,900
| -69% | -$6.69M | 0.01% | 1053 |
|
|
2023
Q2 | $10.9M | Buy |
207,941
+94,700
| +84% | +$5.77M | 0.03% | 458 |
|
|
2023
Q1 | $7.24M | Buy |
113,241
+3,900
| +4% | +$255K | 0.02% | 659 |
|
|
2022
Q4 | $5.31M | Buy |
109,341
+10,500
| +11% | +$659K | 0.01% | 762 |
|
|
2022
Q3 | $6.97M | Sell |
98,841
-41,300
| -29% | -$3.53M | 0.02% | 607 |
|
|
2022
Q2 | $9.94M | Sell |
140,141
-15,800
| -10% | -$1.02M | 0.03% | 507 |
|
|
2022
Q1 | $12.5M | Buy |
155,941
+6,800
| +5% | +$506K | 0.03% | 439 |
|
|
2021
Q4 | $13.6M | Buy |
149,141
+7,500
| +5% | +$805K | 0.03% | 415 |
|
|
2021
Q3 | $18.2M | Buy |
141,641
+71,800
| +103% | +$10M | 0.05% | 337 |
|
|
2021
Q2 | $10.7M | Buy |
69,841
+19,800
| +40% | +$2.61M | 0.03% | 541 |
|
|
2021
Q1 | $5.28M | Buy |
+50,041
| New | +$5.01M | 0.01% | 830 |
|
|
2020
Q4 | – | Sell |
-111,741
| Closed | -$6.32M | – | 2573 |
|
|
2020
Q3 | $6.32M | Sell |
111,741
-17,900
| -14% | -$964K | 0.02% | 687 |
|
|
2020
Q2 | $7.98M | Sell |
129,641
-36,000
| -22% | -$1.47M | 0.02% | 635 |
|
|
2020
Q1 | $5.34M | Sell |
165,641
-77,100
| -32% | -$2.6M | 0.02% | 688 |
|
|
2019
Q4 | $8.54M | Sell |
242,741
-19,900
| -8% | -$657K | 0.02% | 643 |
|
|
2019
Q3 | $6.77M | Sell |
262,641
-30,200
| -10% | -$918K | 0.02% | 665 |
|
|
2019
Q2 | $8.6M | Buy |
292,841
+3,800
| +1% | +$110K | 0.02% | 634 |
|
|
2019
Q1 | $9.88M | Buy |
289,041
+23,700
| +9% | +$839K | 0.02% | 603 |
|
|
2018
Q4 | $8.47M | Buy |
265,341
+10,900
| +4% | +$425K | 0.02% | 617 |
|
|
2018
Q3 | $12.2M | Buy |
254,441
+23,400
| +10% | +$958K | 0.03% | 531 |
|
|
2018
Q2 | $7.16M | Buy |
231,041
+115,300
| +100% | +$2.7M | 0.02% | 697 |
|
|
2018
Q1 | $1.71M | Buy |
115,741
+2,600
| +2% | +$40.6K | ﹤0.01% | 1313 |
|
|
2017
Q4 | $1.75M | Buy |
113,141
+69,200
| +157% | +$1.03M | ﹤0.01% | 1300 |
|
|
2017
Q3 | $547K | Buy |
43,941
+7,400
| +20% | +$82.5K | ﹤0.01% | 1719 |
|
|
2017
Q2 | $395K | Buy |
36,541
+9,400
| +35% | +$91.9K | ﹤0.01% | 1874 |
|
|
2017
Q1 | $266K | Sell |
27,141
-2,400
| -8% | -$23.9K | ﹤0.01% | 2126 |
|
|
2016
Q4 | $321K | Sell |
29,541
-1,400
| -5% | -$14.2K | ﹤0.01% | 2052 |
|
|
2016
Q3 | $291K | Sell |
30,941
-2,200
| -7% | -$17.7K | ﹤0.01% | 1892 |
|
|
2016
Q2 | $183K | Sell |
33,141
-3,200
| -9% | -$20.7K | ﹤0.01% | 1882 |
|
|
2016
Q1 | $269K | Buy |
+36,341
| New | +$246K | ﹤0.01% | 1721 |
|
|
2015
Q1 | – | Sell |
-11,341
| Closed | -$103K | – | 2350 |
|
|
2014
Q4 | $103K | Buy |
+11,341
| New | +$110K | ﹤0.01% | 2326 |
|
Other funds holding STAA
BC
YC
MF
AAM
Two Sigma Advisers's STAA Position: Q3 2025 in Review
Two Sigma Advisers sold out of STAAR Surgical (STAA) in Q3 2025, closing a stake of 99,141 shares — an estimated $1.66M sold.
Two Sigma Advisers first reported a position in STAA in Q4 2014 and held it in 32 quarters. The position peaked at $18.2M in Q3 2021. 196 funds tracked by Wall St. Rank hold STAA as of Q3 2025.
- Two Sigma Advisers reported no remaining STAAR Surgical position as of Q3 2025 after selling out during the quarter.
- Two Sigma Advisers sold 99,141 STAAR Surgical shares in Q3 2025, an estimated $1.66M.
- Two Sigma Advisers first reported a position in STAAR Surgical in Q4 2014 and held it in 32 quarters.
- Two Sigma Advisers's STAAR Surgical position peaked at $18.2M in Q3 2021.
- 196 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2025.
Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.